by Tom Finkel
Here's the headline I put on the blog entry I just posted about the U.S. Food and Drug Administration's and Federal Trade Commission's responses to complaints from Monsanto that U.S. milk producers are "misleading" the citizenry about the Creve Coeur-based chemical company's product Posilac, a.k.a. rBST, a.k.a. recombinant bovine somatotropin, a.k.a. bovine growth hormone:
Now here's the headline from the Business page of yesterday's St. Louis Post-Dispatch, atop a story by Rachel Melcer that covers the exact-same topic:
Well, here we go again.
I'm not going to go over all the old ground. Let me just point you to the only other story about the denouement that's appeared so far, written by Associated Press writer Sam Hananel. That story was published in various newspapers around the nation under this headline: